The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma.

Autor: Wang, Xing1 (AUTHOR) 1511110402@bjmu.edu.cn, Wang, Dedao1 (AUTHOR) 1911210644@pku.edu.cn, Ding, Ning1 (AUTHOR) ningding@bjmu.edu.cn, Mi, Lan1 (AUTHOR) milan@bjmu.edu.cn, Yu, Hui1 (AUTHOR) yuhuidoc@bjmu.edu.cn, Wu, Meng1 (AUTHOR) lxywumeng@bjmu.edu.cn, Feng, Feier1 (AUTHOR) feierfeng@bjmu.edu.cn, Hu, Luni2 (AUTHOR) huluni@hsc.pku.edu.cn, Zhang, Yime2 (AUTHOR) 1711110047@bjmu.edu.cn, Zhong, Chao2 (AUTHOR) zhongc@hsc.pku.edu.cn, Ye, Yingying1 (AUTHOR) 1811110577@bjmu.edu.cn, Li, Jiao1 (AUTHOR) lja03081@btch.edu.cn, Fang, Wei1 (AUTHOR) fangwei@pku.org.cn, Shi, Yunfei3 (AUTHOR) shiyunfei@bjmu.edu.cn, Deng, Lijuan1 (AUTHOR) denglj@bjmu.edu.cn, Ying, Zhitao1 (AUTHOR) yingzhitao@bjmu.edu.cn, Song, Yuqin1 (AUTHOR) songyuqin@bjmu.edu.cn, Zhu, Jun1 (AUTHOR) songyuqin@bjmu.edu.cn
Zdroj: Cancers. Sep2021, Vol. 13 Issue 17, p4249. 1p.
Databáze: Academic Search Ultimate